News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Sentigen Holding Corp. Announces Second Quarter Results
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Sentigen Holding Corp. (NasdaqSC: SGHL), today reported results for the second quarter ended June 30, 2004.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
IPO
Windward nets $175M IPO, bringing 2026 biotech debuts to 35
November 13, 2026
·
1 min read
·
Gabrielle Masson
Drug Development
Regeneron’s POTS antibody curbs heart rate spikes, teeing up Phase 3 trial
November 13, 2026
·
3 min read
·
Gabrielle Masson
Venture capital
Neurosterix nabs $105M, recruits Karuna veterans for schizophrenia push
November 12, 2026
·
2 min read
·
Gabrielle Masson
Funding
Pfizer snags $1.5B financing from PE firm Blackstone to support Metsera asset
November 12, 2026
·
2 min read
·
Annalee Armstrong